Polaryx Therapeutics, Inc. (PLYX)

Price & Market Data

Price: $2.60

Daily Change: -$1.00 / 38.46%

Daily Range: $2.33 - $3.78

Market Cap: $122,145,704

Daily Volume: 1,207,940

Performance Metrics

1 Week: 26.32%

1 Month: -33.70%

3 Months: 46.94%

6 Months: -92.00%

1 Year: -92.00%

YTD: -92.00%

About Polaryx Therapeutics, Inc. (PLYX)

A complete market overview for Polaryx Therapeutics, Inc. (PLYX). The stock is at 2.60, with a daily change of -$1.00 / 38.46%. Market cap: 122,145,704. Delve into its YTD and 3-month performance.

Company Details

Employees: 11

Sector: Commercial services

Industry: Miscellaneous commercial services

Country: United States

Details

Polaryx Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of disease-modifying therapies for rare and pediatric lysosomal storage disorders in the United States. Its pipeline includes PLX-100, a preclinical stage orally administrable combination therapy; PLX-200, a repurposed oral small molecule for the treatment of LSDs; PLX-300, a preclinical stage orally administrable combination therapy; and PLX-400, a preclinical stage novel gene therapy candidate. The company was founded in 2014 and is based in Paramus, New Jersey.

Selected stocks

Lakewood-Amedex Biotherapeutics Inc. (LABT)

Air Global PLC (AIIR)

Nicola Mining Inc. (NICM)

Russell 2000 ETF (IWM)

EquipmentShare.com Inc (EQPT)